Prevención secundaria en pacientes revascularizados coronarios en Uruguay: descripción de un programa, evaluación del control de los factores de riesgo y efecto en la mortalidad

Comisión Honoraria para la Salud Cardiovascular. Área de Epidemiología y Estadística. Resumen del análisis de Mortalidad Cardiovascular en Uruguay, años 2005 y 2006 [consultado 5/12/2007]. Disponible en: http://cardiosalud.org/novedades/informe-2004-2005-2006/3_salud:cardiovascular_21_40.pdf. Gambogi R, Debenedetti A, Albornoz H, Gonzalez M, Scarpitta C, Ketzoian C et al. Programa de seguimiento, Cirugía de Revascularización Coronaria. Fondo Nacional de Recursos, publicación interna distribuida entre las Instituciones de Medicina Altamente Especializada. [consultado 8/2001]. Disponible en: biblioteca del FNR, [email protected] 1996, A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events), Heart, 75, 334, 10.1136/hrt.75.4.334 1997, EUROASPIRE: A European Society of Cardiology survey of secondary prevention of coronary heart disease, principal results, Eur Heart J, 18, 1582 2001, Lifestyle and risk factor management and use of drugs therapies in coronary patients from 15 countries: Principal results from EUROASPIORE II, Eur Heart J, 22, 554, 10.1053/euhj.2001.2610 2001, Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries, Lancet, 357, 995, 10.1016/S0140-6736(00)04235-5 Pearson, 1998, The American College of Cardiology Evaluation of Preventive Therapeutics (ACCEPT) Study: Attainment goals for comprehensive risk reduction in patients with coronary disease in US, J Am Coll Cardiol, 31, 186, 10.1016/S0735-1097(98)81447-2 Pearson, 2000, The Lipid Treatment Assessment Project (L-TAP): A multi-center survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving lipoprotein cholesterol goals, Arch Intern Med, 160, 459, 10.1001/archinte.160.4.459 Haskell, 1994, Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease, Circulation, 89, 975, 10.1161/01.CIR.89.3.975 Campbell, 1998, Secondary prevention in coronary heart disease: Baseline survey of provision in general practice, BMJ, 316, 1430, 10.1136/bmj.316.7142.1430 De Busk, 1994, A case-management system for coronary risk factor modification after acute myocardial infarction, Ann Intern Med, 120, 721, 10.7326/0003-4819-120-9-199405010-00001 Fonarow, 2001, Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP), Am J Cardiol, 87, 819, 10.1016/S0002-9149(00)01519-8 McAlister, 2001, Randomised trials of secondary prevention programs in coronary heart disease: Systematic review, BMJ, 323, 957, 10.1136/bmj.323.7319.957 Murchie, 2003, Secondary prevention clinics for coronary heart disease: Four year follow up of a randomized controlled trial in primary care, BMJ, 326, 1, 10.1136/bmj.326.7380.84 Wood, 2008, Lancet, 371, 1999, 10.1016/S0140-6736(08)60868-5 Giannuzzi, 2006, Global secondary prevention strategies to limit event recurrence after myocardial infarction: The GOSPEL study. A trial from the Italian Cardiac Rehabilitation Network: Final results., Circulation. Abstract 3964, 114, II_852 Dalal, 2004, Recent developments in secondary prevention and cardiac rehabilitation after acute myocardial infarction, BMJ, 328, 693, 10.1136/bmj.328.7441.693 Balady, 2000, A statement of healthcare professionals from the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation, Circulation, 102, 1069, 10.1161/01.CIR.102.9.1069 Giannuzzi, 2003, Secondary prevention through cardiac rehabilitation. Position paper of The Working Group on Cardiac Rehabilitation and Exercise Physiology of the European Society of Cardiology, Eur Heart J, 24, 1273, 10.1016/S0195-668X(03)00198-2 Sociedad Uruguaya de Aterosclerosis, Sociedad Uruguaya de Cardiología. Primer Consenso Nacional de Aterosclerosis; Recomendaciones para la Prevención y el Tratamiento de la Aterosclerosis; 2004 [consultado 10/12/2007]. Disponible en: http://www.suc.org.uy/pdf/Consenso%20SUC-Aterosclerosis.pdf Sociedad Uruguaya de Hipertensión Arterial. Tercer Consenso Uruguayo de Hipertensión Arterial; octubre 2005 [consultado 10/12/2007]. Disponible en: http://www.suc.org.uy/pdf/consenso%20ha3.pdf AHA/ACC Guidelines for Secondary Prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update. Endorsed by National Heart, Lung, and Blood Institute. Circulation 2006;113:2363–72. European guidelines on cardiovascular disease prevention in clinical practice. Third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur Heart J. 2003;24:1601–10. Sackett, 1975, Randomized clinical trial of strategies for improving medication compliance in primary hypertension, Lancet, 1, 1205, 10.1016/S0140-6736(75)92192-3 Morisky, 1986, Concurrent and predictive validity of a self-reported measure of medication adherence, Med Care, 24, 67, 10.1097/00005650-198601000-00007 Hosmer, 1999 Gray, 1988, A class of k-sample tests for comparing the cumulative incidence of a competing risk, Ann Statist, 16, 1141, 10.1214/aos/1176350951 Pintilie, 2006 R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Viena, Austria; 2008. ISBN 3-900051-07-0. [consultado: 9/2008] Disponible en: http://www.R-project.org. Gambogi R, Debenedetti A, Albornoz H, Gonzalez M, Scarpitta C, Ketzoian C et al. Seguimiento de procedimientos cardiológicos invasivos. Fondo Nacional de Recursos, publicación interna distribuida entre las Instituciones de Medicina Altamente Especializada. [consultado 5/2003]. Disponible en: biblioteca del FNR, [email protected] LaBresh, 2004, Get with the guidelines for cardiovascular secondary prevention. Pilot results, Arch Intern Med, 164, 203, 10.1001/archinte.164.2.203 De Velasco, 2004, Programa de intervención para mejorar la prevención secundaria del infarto de miocardio. Resultados del estudio PRESENTE (PREvención SEcuNdaria TEmprana), Rev Esp Cardiol, 57, 146, 10.1157/13057265 Sandoya, 2005, Elementos asociados al buen control de la presión arterial en individuos hipertensos, Rev Urug Cardiol, 20, 86 European guidelines on cardiovascular disease prevention in clinical practice. Atherosclerosis. 2007;194:1–45. 2002, MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: A randomized placebo-controlled trial, Lancet, 360, 7, 10.1016/S0140-6736(02)09327-3 Cannon, 2004, Intensive versus moderate lipid lowering with statins after acute coronary syndromes, N Engl J Med, 350, 1405, 10.1056/NEJMoa040583 La Rosa, 2005, Intensive lipid lowering with atorvastatin in patients with stable coronary disease, N Engl J Med, 352, 1425, 10.1056/NEJMoa050461 Correa F, Manfredi A, Gambogi R, Rosello C, Lombide I. Control de lípidos en prevención secundaria. Abstract. XVI Congreso Uruguayo de Cardiología. 2000. Dornelas, 2000, A randomized controlled trial of smoking cessation counseling after myocardial infarction, Prev Med, 30, 261, 10.1006/pmed.2000.0644 Willich, 2001, Cardiac risk factors, medication, and recurrent clinical events after acute coronary disease, Eur Heart J, 22, 307, 10.1053/euhj.2000.2294 Ministerio de Salud Pública. 1.a Encuesta Nacional de Factores de Riesgo de Enfermedades Crónicas No Trasmisibles. Mayo 2007 [consultado 11/12/2007]. Disponible en: http://www.msp.gub.uy/imgnoticias/12794.ppt#23. Ogden, 2000, The correlates of long-term weight loss: A group comparison study of obesity, Int J Obes, 24, 1018, 10.1038/sj.ijo.0801354 Perri, 2003, Success and failure maintenance of lost weight, 439 Hall, 1992, Weight gain prevention and smoking cessation: Cautionary findings, Am J Public Health, 82, 799, 10.2105/AJPH.82.6.799 Clark, 2004, Weight concerns among male smokers, Addict Behav, 29, 1637, 10.1016/j.addbeh.2004.02.034 Sidney, 2000, Clinical treatment of dyslipidemia: Practice patterns and missed opportunities, Am J Cardiol, 86, 62, 10.1016/S0002-9149(00)01473-9 Cambou, 1999, Secondary prevention of patients with acute coronary syndrome in France: The PREVENIR survey, The Lancet Conference. Challenge Acute Coronary Syndromes, 11, 68 Boden, 2007, Optimal medical therapy with or without PCI for stable coronary disease, N Engl J Med, 356, 1503, 10.1056/NEJMoa070829